Pharmacovigilance and Drug Safety

It deals with prevention of  adverse drug reaction by collection, detection, assessment, monitoring. It concerns with the identifying hazards associated with pharmaceutical formulation. The advancement associated with pharmacovigilance helps in producing the valid formulation by focussing on the collected data from patients and health care providers.

Patient awareness regarding adverse drug events is stimulating global pharmacovigilance market growth by increase in number of national pharmacovigilance centers. Spain pharmacovigilance market size was valued over USD 230 million in 2015 and witness 10.2% CAGR from 2016 to 2024, to surpass USD 550 million by 2024.

  • Adverse Event Reporting
  • Risk Management Plans
  • The Importance of Pharmacovigilance, Safety Monitoring of Medicinal Products
  • Role of Pharmacovigilance Centres

Related Conference of Pharmacovigilance and Drug Safety

October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Pharmacovigilance and Drug Safety Conference Speakers

Recommended Sessions

Related Journals

Are you interested in